Prakt. lékáren. 2018; 14(1): 36-39 | DOI: 10.36290/lek.2018.057

Smoking cessation – how can a pharmacist help?

Dana Syrová
Nemocniční lékárna VFN Praha

Smoking and a tobacco addiction is a chronic disease being among the risk factors for the emergence of a range of diseases.Smokers are a threatened group even for postoperative complications and for the process of the operation itself. Passive smokingis also underestimated. There are more than 2 million people addicted to tobacco in the Czech Republic, 18 000 people out ofwhich annually die. Half of smokers die 15 years earlier than if they would not smoke. At the beginning of smoking social addictiondominates which is then being developed to psychological and later on to physical addiction. To quit smoking has significance atany age. Getting rid of addiction is very difficult without help and that is why doctors have begun setting up specialized centres.To make the assistance to smokers available as broad as possible, also pharmacists take part in this activity. Trained pharmacistsprovide professional counselling at pharmacies for giving up smoking. The pharmacists evaluate the status of the smoker andpropose an individual cessation plan including therapy and crisis management. However, any intervention or offer of educationalmaterials supporting non-smoking are significant.

Keywords: tobacco, tobacco addiction, pharmacist – expert advisor, giving up smoking in the pharmacy, treatment options

Received: March 23, 2017; Accepted: March 25, 2017; Published: March 24, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Syrová D. Smoking cessation – how can a pharmacist help? Praktické lékárenství. 2018;14(1):36-39. doi: 10.36290/lek.2018.057.
Download citation

References

  1. Králíková E, et al. Závislost na tabáku - epidemiologie, prevence a léčba. Praha: Adamíra 2013: 503 s.
  2. Peto R, Lopez AD, Boreham J, et al. Mortality from smoking in developed countries 1950-2005 (update March 2015 or later). Oxford University Press: Oxford. Dostupné na WWW: http://www.ctsu.ox.ac.uk/~tobacco/.
  3. Wong J, Lam DP, Abrishami A, et al. Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis. Can J Anaesth 2012; 59(3): 268-279. Go to original source... Go to PubMed...
  4. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2011: Warning about the dangers of tobacco. Dostupné na www: http://www.who.int/tobacco/global_report/2011/ Geneva: WHO, 2011.
  5. Eriksen M, Mackay J, Ross H. Tobacco Atlas, 4. vydání. Atlanta, USA: ACS, WLF 2012. Dostupné na WWW: http://www.tobaccoatlas.org.
  6. Váňová A, Skývová M, Csémy L. Užívání tabáku a alkoholu v České republice 2016. Vydal Státní zdravotní ústav 2017. Dostupné na WWW: http://www.szu.cz/uploads/documents/szu/aktual/uzivani_tabaku_2016_konecny_17_7.pdf
  7. Greplová J. Prevalence kouření a postoje k užívání tabáku mezi nezletilými v České republice. Adiktologie 2013; 13(3-4): 240-247.
  8. Lee KM, Ward MH, Han S, Ahn HS, Kang HJ, Choi HS, Shin HY, Koo HH, Seo JJ, Choi JE, Ahn YO, Kang D. Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Leukemia Research 2009; 33(2): 250-258. Go to original source... Go to PubMed...
  9. Schultz KPA, Chen L, Chen Z, Zeltzer LK, Nicholson HS, Neglia JP. Health and risk behaviors in survivors of childhood acute myeloid leukemia: A report from the children's oncology group. Pediatr Blood Cancer 2010; 55: 157-164. Go to original source... Go to PubMed...
  10. Kavalírová L, et al. Doporučený postup - odvykání kouření. Česká lékárnická komora 2010. Dostupné na WWW: http://lekarnici.cz/Pro-verejnost/PORADENSTVI-KONZULTACE/PORADENSTVI-KONZULTACE/Doporuceny-postup-Odvykani-koureni.aspx.
  11. Králíková E, Býma S, Cífková R, Češka R, Dvořák V, Hamanová J, Horký K, Hradec J, Keller O, Konštacký S, Kos S, Kostřica R, Kunešová M, Kvapil M, Langrová K, Mayer O, Petrů V, Popov P, Raboch J, Rosolová H, Roztočil K, Sucharda P, Vorlíček J, Widimský J. Doporučení pro léčbu závislosti na tabáku. Časopis lékařů českých 2005; 144(5): 327-333. Go to PubMed...
  12. Králíková E, Češka R, Pánková A, Štěpánková L, Zvolská K, Felbrová V, Kulovaná S, Zvolský M. Doporučení pro léčbu závislosti na tabáku. Vnitř Lék 2015; (Suppl 1)61: 3-15.
  13. Heatherton F, Kozlowski LT, Frecker RC, et al. The Fagerström test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991; 86(9): 1119-1127. Go to original source... Go to PubMed...
  14. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerström Test for Cigarette Dependence. Nicotine Tob Res 2012; 14(1): 75-78. Go to original source... Go to PubMed...
  15. Králíková E. Nové možnosti v léčbě závislosti na tabáku. Interní Med. 2008; 10(10): 444-448.
  16. Benowitz NL. Summary: Risks and Benefits. In: Benowitz NL (Ed). Nicotine Safety and Toxicity. New York Oxford University Press 1998; 185-195.
  17. Nicotine Replacement Therapy, Guidance for health professionals on changes in the licensing arrangements for nicotine replacement therapy. ASH London December 2005. Dostupný na WWW: http://www.ash.org.uk/html/cessation/smoking%20REDUCTION/nrt051229.pdf.




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.